News
A a key signalling pathway is activated when cancer cells change shape in response to the chemotherapy drugs taxanes – giving us new clues as to how they work.
New AIBN group leader Dr Richard Lobb is developing a blood test to diagnose and monitor neurological diseases including brain cancer, MND and dementia.
Join The Network
Stay on top of our industry news and developments, events and opportunities, by joining The Network
Meet our researchers
Read nowFollow us
Features
Researchers from The University of Queensland are using synthetic biology to help the world’s biggest businesses transition to net zero.
Work on a new range of hyper accurate cancer drugs has begun with the launch of an Australian-first research and manufacturing hub.
- 22 September 2025
- 3 September 2025
Partner with us
Contact us and learn how our scientific expertise and cutting edge facilities could help you reach your goals.
